Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEnterprise ValueEquity AverageInventory AverageInvested CapitalMarket Capitalization

Zhengye Biotechnology Holding (ZYBT) Equity Average: 2023-2024

Historic Equity Average for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $48.2 million.

  • Zhengye Biotechnology Holding's Equity Average was N/A to $49.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $49.4 million, marking a year-over-year change of. This contributed to the annual value of $48.2 million for FY2024, which is 4.79% down from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Equity Average of $48.2 million as of FY2024, which was down 4.79% from $50.6 million recorded in FY2023.
  • Zhengye Biotechnology Holding's 5-year Equity Average high stood at $50.6 million for FY2023, and its period low was $48.2 million during FY2024.
  • In the last 2 years, Zhengye Biotechnology Holding's Equity Average had a median value of $49.4 million in 2024 and averaged $49.4 million.
  • Data for Zhengye Biotechnology Holding's Equity Average shows a maximum YoY decreased of 4.79% (in 2024) over the last 5 years.
  • Over the past 2 years, Zhengye Biotechnology Holding's Equity Average (Yearly) stood at $50.6 million in 2023, then dropped by 4.79% to $48.2 million in 2024.